Condition
Impaired Fasting Glucose (IFG)
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07263802Not ApplicableNot Yet RecruitingPrimary
Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism
NCT06955234Not ApplicableNot Yet RecruitingPrimary
Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose
NCT02969798Not ApplicableRecruiting
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
NCT03398356Phase 4Completed
Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.
NCT00787215Unknown
A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese
Showing all 5 trials